NDC 70677-1013-01 - Foster and Thrive Mucus Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-1013
- Requested NDC
- 70677-1013-01
- Package NDCs from labels
- 70677-1013-1, 70677-1013-2, 70677-1013-3, 70677-1013-01
- Manufacturer
- Strategic Sourcing Services LLC
- Effective date
- 2026-09-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Foster and Thrive Mucus Relief - Strategic Sourcing Services LLC | Strategic Sourcing Services LLC | 2026-09-09 | Human OTC Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-1013-1 | Foster and Thrive Mucus Relief | 10 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 10 | 2 | |
| 70677-1013-1 | Foster and Thrive Mucus Relief | 4 in 1 CARTON | TABLET, EXTENDED RELEASE | 4 | 2 | |
| 70677-1013-2 | Foster and Thrive Mucus Relief | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-1013 | FOSTER AND THRIVE MUCUS RELIEF (GUAIFENESIN) TABLET, EXTENDED RELEASE [STRATEGIC SOURCING SERVICES LLC] | 1 | Current NDC, 3 package rows | 20230414_f4ab5611-8abb-4c1f-8f85-917e2e1328e3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-1013-1 | EA - Each | 70677-1013 | 00c3f9f4-9661-4639-af62-b6af9cb80e81 | 1 | 2023-08-08 |
| 70677-1013-2 | EA - Each | 70677-1013 | 08fa70e3-2433-42a4-b8fe-24d37ab2a7fc | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MUCUS RELIEF | GUAIFENESIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 2caa7f8e-695c-441a-a968-fcc3f527d117 | 2026-05-13 | Warnings | 636522 495W7451VQ |
| GILTUSS DIABETIC EX | GILTUSS DIABETIC EX | Gil Pharmaceutical Corp | ab7915e7-323a-4fe1-887a-a3bd3f0aac98 | 2026-05-13 | Warnings | 636522 495W7451VQ |
| Giltuss EX Maximum Strength Expectorant | GILTUSS EX MAXIMUM STRENGTH EXPECTORANT | Gil Pharmaceutical Corp | 950db1ca-6936-47f8-a112-e3594d4c922c | 2026-05-13 | Warnings | 495W7451VQ |
| Giltuss EX Expectorant | GILTUSS EX EXPECTORANT | Gil Pharmaceutical Corp | 3b363fb9-c4d3-446f-927c-f705ffc715b5 | 2026-05-13 | Warnings | 636522 495W7451VQ |
| Giltuss HBP EX Expectorant | GILTUSS HBP EX EXPECTORANT | Gil Pharmaceutical Corp | 31bd6356-27cf-4188-8fd5-9cd9392021ca | 2026-05-13 | Warnings | 636522 495W7451VQ |
| Mucinex Fast-Max DM Max | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | Reckitt Benckiser LLC | 6a8cdcad-4881-49b8-a3f1-2c1574300d18 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Chest Congestion Honey and Berry Flavor | GUAIFENESIN | Reckitt Benckiser LLC | 8ec74cf2-88f5-40be-87e2-b756ab841754 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Cold and Flu | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE | Reckitt Benckiser LLC | c16253d3-3824-458c-8840-e3a2fbe7682c | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Severe Congestion and Cough | GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE | Reckitt Benckiser LLC | 1991d5ee-fc90-4070-8965-cd6f4abc45cf | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Severe Congestion and Cough | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | a25278bd-c3b9-4db3-b4f7-b395eb5f9177 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Fast-Max Cold, Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | a3523aa3-9ed1-472d-9986-438440d0a3eb | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Sinus-Max Severe Congestion Relief | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 128f3442-9802-4303-80be-aead09237936 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Sinus-Max Severe Congestion and Pain, Maximum Strength | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 2c01962d-74e3-4dfa-b7cb-a91a687711d5 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Sinus-Max Pressure, Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | f5365c6d-9296-41a5-953a-d1008954e67f | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Sinus-Max Pressure, Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 8905706b-b9da-4520-8cf2-87d7c125edf3 | 2026-05-13 | Warnings | 495W7451VQ |
| Maximum Strength Mucinex Sinus-Max Pressure, Pain and Cough | ACETAMINOPHEN, GUAIFENESIN | Reckitt Benckiser LLC | 350764de-7801-b24e-e063-6394a90ab3c3 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Cold and Flu | ACETAMINOPHEN, GUAIFENESIN | Reckitt Benckiser LLC | e8bc4131-f7b0-926a-e053-2995a90a40ac | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Cold, Flu, and Sore Throat | ACETAMINOPHEN, GUAIFENESIN | Reckitt Benckiser LLC | 37ded76a-ee8d-f22c-e063-6394a90a00c2 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex Cough Chest Congestion | DEXTROMETHORPHAN HBR, GUAIFENESIN | Reckitt Benckiser LLC | e9c32d81-cd9b-4ff2-e053-2995a90aa499 | 2026-05-13 | Warnings | 495W7451VQ |
| Mucinex | GUAIFENESIN | Cardinal Health 107, LLC | 8b0d6d01-f1dd-41b0-a71e-46668bc9cde6 | 2026-05-12 | Warnings | 636522 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.